Supriya Koya in Oklahoma City, Oklahoma

Home Oklahoma Oklahoma City

Supriya Koya has Medical Oncology as her primary medical specialty. Their primary office is: 11100 Hefner Pointe Dr in Oklahoma City, Oklahoma. There are 2 additional office locations for Supriya Koya that can be viewed towards the end of their profile.

They're a part of the: Genesiscare Landmark Oklahoma Cancer Care Pc medical group which has around 19 members. You can call their office at 405-839-7340 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2000 (around 24 years of experience). They are listed as doing telehealth appointments.

Supriya Koya Office Phone and Directions

Supriya Koya
Genesiscare Landmark Oklahoma Cancer Care Pc
11100 Hefner Pointe Dr
Oklahoma City, Oklahoma 73120
405-839-7340

Patient Ratings
Please rate your experience with Supriya Koya below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 405-839-7340

Enter a starting address:

Healthcare Info for Supriya Koya

Additional Medical Specialties Include:
HEMATOLOGY/ONCOLOGY, INTERNAL MEDICINE

Medical School: Sorry, her university is not listed
Graduation Year: 2000
The Primary Medical Specialty for Supriya Koya is listed as: Medical Oncology
Approximate Years of Experience: 24
PAC (PECOS ID)#: 2163614280
NPI #: 1770790289
NPI Created On: 05/16/2007
NPI Last Updated Listed as: 01/12/2016
Primary Taxonomy Code: 207RH0003X
License Number:
27704
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Application of on-body injector for injection under skin
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 5 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Injection, pegfilgrastim, 6 mg

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $99

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788667015

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788667017

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788667019

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788667021

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788667023

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788667025

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781012043

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781012045

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818704949

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818761621

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60

Additional Office Locations

1. Genesiscare Landmark Oklahoma Cancer Care Pc
609 Virginia Ave
Ponca City, OK 74601
Group Members: 19

Phone: 405-839-7340

Enter a starting address:

2. Ahs Oklahoma Physician Group Llc
1245 S Utica Ave
Tulsa, OK 74104
Fl 1
Group Members: 303

Phone: 405-839-7340

Enter a starting address:

Medical Oncology Professionals in Oklahoma City

1.
Brian Geister

5915 W Memorial Rd
Oklahoma-city, OK
Integris Ambulatory Care Corporation

2.
Todd Kliewer MD

608 Nw 9th St
Oklahoma-city, OK
Saint Medical Group, Llc

3.
Agnel Raparthi

3300 Nw Expressway
Oklahoma-city, OK
Integris Ambulatory Care Corporation

4.
Bashar Alasad

4301 S Western Ave
Oklahoma-city, OK
Integris Ambulatory Care Corporation

5.
Romeo Mandanas MD

5915 W Memorial Rd
Oklahoma-city, OK
Integris Ambulatory Care Corporation

6.
Abdul Rafeh Naqash

800 Ne 10th St
Oklahoma-city, OK
Ou Health Partners Inc

Providers in Genesiscare Landmark Oklahoma Cancer Care Pc

1.Stephen Back

11100 Hefner Pointe Dr
Oklahoma City Ok 73120-5049
Genesiscare Landmark Oklahoma Cancer Care Pc
Diagnostic Radiology

2.Stephen Back

4500 S Garnett Rd
Tulsa Ok 74146-5201
Genesiscare Landmark Oklahoma Cancer Care Pc
Diagnostic Radiology

3.Amaya Basta

11100 Hefner Pointe Dr
Oklahoma City Ok 73120-5049
Genesiscare Landmark Oklahoma Cancer Care Pc
Diagnostic Radiology

4.Amaya Basta

4500 S Garnett Rd
Tulsa Ok 74146-5201
Genesiscare Landmark Oklahoma Cancer Care Pc
Diagnostic Radiology

5.Damon Brooks

744 W 9th St
Tulsa Ok 74127-9907
Genesiscare Landmark Oklahoma Cancer Care Pc
Diagnostic Radiology

6.Damon Brooks

10109 E 79th St
Tulsa Ok 74133-4564
Genesiscare Landmark Oklahoma Cancer Care Pc
Diagnostic Radiology

View all 19 members of Genesiscare Landmark Oklahoma Cancer Care Pc medical group